SHOULDER INNOVATIONS, INC. Increase (Decrease) in Accounts Payable
SHOULDER INNOVATIONS, INC. (SI) reported Increase (Decrease) in Accounts Payable of -$2.22 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $997.00K, a 67.88% decline year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$3.22M.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $1.58M, a 27.52% decline year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $807.00K, a 392.07% increase year-over-year.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts payable for fiscal 2025 was $3.37M, a 7.84% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. increase (decrease) in accounts payable for fiscal 2024 was $3.12M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $997.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.22M 10-Q · filed 2026-08-06 | -$642.00K derived: sum of 3 quarters · filed 2026-08-06 | $165.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$3.22M 10-Q · filed 2026-05-13 | -$1.64M derived: sum of 2 quarters · filed 2026-05-13 | -$832.00K derived: sum of 3 quarters · filed 2026-05-13 | $2.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.39M derived: sum of 2 quarters · filed 2026-03-10 | $5.49M derived: sum of 3 quarters · filed 2026-08-06 | $3.37M 10-K · filed 2026-03-10 |
| 2025-09-30 | $807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.91M derived: sum of 2 quarters · filed 2026-08-06 | $1.79M 10-Q · filed 2025-11-12 | $3.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $982.00K 10-Q · filed 2026-08-06 | $3.16M derived: sum of 3 quarters · filed 2026-08-06 | $3.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.12M 10-Q · filed 2026-05-13 | $58.00K derived: sum of 2 quarters · filed 2026-05-13 | $222.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.34M derived: sum of 2 quarters · filed 2026-03-10 | $3.12M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $944.00K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $780.00K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |